U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C10H14BrNO2.BrH
Molecular Weight 341.04
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2C-B HYDROBROMIDE

SMILES

Br.COC1=CC(CCN)=C(OC)C=C1Br

InChI

InChIKey=WGWOFNYIBCKZMV-UHFFFAOYSA-N
InChI=1S/C10H14BrNO2.BrH/c1-13-9-6-8(11)10(14-2)5-7(9)3-4-12;/h5-6H,3-4,12H2,1-2H3;1H

HIDE SMILES / InChI

Molecular Formula BrH
Molecular Weight 80.912
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C10H14BrNO2
Molecular Weight 260.128
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
27.0 nM [EC50]
PubMed

PubMed

TitleDatePubMed
Metabolism of designer drugs of abuse: an updated review.
2010-06-01
Cerebral vasculopathy after 4-bromo-2,5-dimethoxyphenethylamine ingestion.
2010-05
Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of "hallucinogenic designer drugs" in urine of consumers.
2008-06-09
Disposition of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) and its metabolite 4-bromo-2-hydroxy-5-methoxyphenethylamine in rats after subcutaneous administration.
2008-04-21
Comparative potencies of 3,4-methylenedioxymethamphetamine (MDMA) analogues as inhibitors of [3H]noradrenaline and [3H]5-HT transport in mammalian cell lines.
2007-12
Studies on the toxicological detection of the designer drug 4-bromo-2,5-dimethoxy-beta-phenethylamine (2C-B) in rat urine using gas chromatography-mass spectrometry.
2007-02-01
1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists.
2006-09-21
Optimization of the separation and on-line sample concentration of phenethylamine designer drugs with capillary electrophoresis-fluorescence detection.
2006-01-06
A study of the metabolism of methamphetamine and 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in isolated rat hepatocytes.
2005-03-10
Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including human.
2005-01-05
Metabolism of the designer drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in mice, after acute administration.
2004-11-25
A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS.
2004-09
4-Bromo-2,5-dimethoxyphenethylamine (2C-B) and structurally related phenylethylamines are potent 5-HT2A receptor antagonists in Xenopus laevis oocytes.
2004-04
Simultaneous determination of amphetamine derivatives in human urine after SPE extraction and HPLC-UV analysis.
2004-03
4-Bromo-2,5-dimethoxyphenethylamine (2C-B): a review of the public domain literature.
2003-03-14
In vivo metabolism of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in the rat: identification of urinary metabolites.
2002-03
Automated headspace solid-phase microextraction and in-matrix derivatization for the determination of amphetamine-related drugs in human urine by gas chromatography-mass spectrometry.
2002-01
Fluorometric determination of DL-fenfluramine, DL-norfenfluramine and phentermine in plasma by achiral and chiral high-performance liquid chromatography.
2001-11-05
[A case of acute psychotic episode after a single dose of ecstasy].
2001-06-16
WHO Expert Committee on Drug Dependence. Thirty-second report.
2001
Substance Class Chemical
Created
by admin
on Wed Apr 02 11:53:43 GMT 2025
Edited
by admin
on Wed Apr 02 11:53:43 GMT 2025
Record UNII
GE2MXV3PWY
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
2C-B HYDROBROMIDE
Common Name English
BENZENEETHANAMINE, 4-BROMO-2,5-DIMETHOXY-, HYDROBROMIDE (1:1)
Preferred Name English
Code System Code Type Description
FDA UNII
GE2MXV3PWY
Created by admin on Wed Apr 02 11:53:43 GMT 2025 , Edited by admin on Wed Apr 02 11:53:43 GMT 2025
PRIMARY
PUBCHEM
163203510
Created by admin on Wed Apr 02 11:53:43 GMT 2025 , Edited by admin on Wed Apr 02 11:53:43 GMT 2025
PRIMARY
CAS
2001061-73-8
Created by admin on Wed Apr 02 11:53:43 GMT 2025 , Edited by admin on Wed Apr 02 11:53:43 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY